光学基因组映射:解开复杂的变异,并使得在肌肉衰变症中进行精确的诊断
Jiahui Mai1, Jing Duan2, Xiaoyu Chen2
1Department of Neurology, Shenzhen Children's Hospital of China Medical University, No. 7019 Yitian Road, Futian District, Shenzhen, 518038, Guangdong, PR China.
Annals of clinical and translational neurology
|November 22, 2024
概括
光学基因组映射 (OGM) 在标准遗传测试失败时有助于诊断肌痛变异症. 这种先进的技术可以识别DMD基因中的复杂结构变异 (SV),提高罕见遗传突变的诊断准确度.
科学领域:
- 遗传学 是一个遗传学.
- 基因组医学是基因组医学.
- 分子生物学分子生物学
背景情况:
- 发育不良症的诊断可能具有挑战性,传统的基因测试,如多重结合依赖的探针放大 (MLPA) 和下一代测序 (NGS) 在约7%的病例中失败.
- 未被诊断的基因突变限制了对患有骨质疏松症的个体的精确临床管理和干预.
研究的目的:
- 评估光学基因组映射 (OGM) 在检测和表征DMD基因内的复杂结构变异 (SVs) 在未诊断的肌肉变异症患者中的实用性.
- 在传统的遗传检测方法无法得出结论时,提高发育不良症的诊断产量.
主要方法:
- 八名怀疑患有骨质疏松症的患者,先前通过MLPA和NGS对致病变体呈阴性,接受了使用转基因生物的基因检测.
- 收集了临床数据,并使用转基因来识别和分析DMD基因中的结构变异.
主要成果:
- 在MLPA和NGS失败的8名患者中有4名 (50%) 的OGM成功识别了病原性突变.
- 检测到的突变包括X染色体的周心逆转,复杂的重排,以及女性患者的两个X-自基因转位.
- 转基因精确地绘制了X自体转位的断点,并澄清了MLPA在男性患者中建议的复杂重组和删除.
结论:
- 光学基因组映射 (OGM) 是诊断常规遗传测试结果为负的病例中肌变异的有价值的工具.
- 转基因生物有效地识别了复杂的结构变异和染色体异常,有助于及时和适当的患者干预.
相关概念视频
01:17Karyotyping
Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...